Scilex (SCLX) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SCLX Stock Alerts $0.75 -0.08 (-9.69%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineScilex (NASDAQ:SCLX) Trading Down 5.9%marketbeat.com - May 10 at 8:54 PMScilex (NASDAQ:SCLX) Stock Price Down 0.9%marketbeat.com - May 9 at 7:55 PMHC Wainwright Cuts Scilex (NASDAQ:SCLX) Price Target to $8.00americanbankingnews.com - May 7 at 6:22 AMMaintaining Buy Rating on Scilex: Strategic and Financial Optimism Despite Challengesmarkets.businessinsider.com - May 3 at 10:28 PMScilex secures $15 million in registered direct offeringinvesting.com - April 26 at 8:08 PMScilex Holding Company Announces Closing of $15 Million Registered Direct Offeringglobenewswire.com - April 25 at 4:01 PMScilex Holding Company Announces $15 Million Registered Direct Offeringglobenewswire.com - April 24 at 8:00 AMScilex to reduce R&D expenses in 2024, comments on actions post Change Healthcare cyberattackmsn.com - April 16 at 1:08 PMScilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expensesglobenewswire.com - April 16 at 9:00 AMScilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Poolglobenewswire.com - April 9 at 9:00 AMScilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividendglobenewswire.com - March 27 at 9:00 AMScilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patientsglobenewswire.com - March 21 at 9:30 AMScilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Neededglobenewswire.com - March 20 at 11:00 AMScilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®globenewswire.com - March 20 at 9:00 AMScilex Holding repays the remaining balance of convertible debenturesmsn.com - March 19 at 1:05 PMScilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovationglobenewswire.com - March 19 at 9:00 AMScilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canadaglobenewswire.com - March 18 at 9:00 AMSCLX Apr 2024 2.000 putfinance.yahoo.com - March 16 at 10:45 PMSCLX Apr 2024 1.000 putfinance.yahoo.com - March 16 at 5:44 PMScilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.globenewswire.com - March 15 at 2:45 PMScilex Pharma Enters Definitive Mutual Release And Settlement Agreement With Virpaxmarkets.businessinsider.com - March 15 at 10:23 AMScilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlementfinance.yahoo.com - March 15 at 10:23 AMScilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlementglobenewswire.com - March 15 at 9:00 AMZacks Small Cap Analysts Increase Earnings Estimates for Scilex Holding (NASDAQ:SCLX)marketbeat.com - March 15 at 6:49 AMScilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - March 14 at 12:53 PMSCLX Grows Revenue and Boosts Marketingfinance.yahoo.com - March 12 at 7:58 PMScilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25%finance.yahoo.com - March 9 at 8:08 AMQ2 2024 EPS Estimates for Scilex Holding Boosted by Analyst (NASDAQ:SCLX)marketbeat.com - March 7 at 6:55 AMSCLX Continues to Make Stridesmsn.com - March 6 at 7:35 PMScilex Holding Company Announces Closing of $10 Million Bought Deal Offeringglobenewswire.com - March 5 at 4:01 PMScilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024globenewswire.com - March 5 at 9:00 AMScilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updatesglobenewswire.com - March 4 at 9:00 AMScilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024globenewswire.com - March 2 at 3:25 PMScilex Holding Shares Drop 31% After $10M Offering Pricesmarketwatch.com - March 1 at 3:22 PMScilex to raise $10M via bough deal offeringmsn.com - February 29 at 10:31 PMScilex Holding Company Announces $10 Million Bought Deal Offeringglobenewswire.com - February 29 at 5:32 PMScilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.globenewswire.com - February 28 at 9:00 AMScilex and Sorrento settle with Virpax and its founder Anthony Mackmsn.com - February 27 at 9:21 AMScilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)globenewswire.com - February 27 at 9:00 AMLatest News for Scilex Holding Stock (NASDAQ:SCLX)benzinga.com - February 26 at 11:16 PMScilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreementfinance.yahoo.com - February 26 at 6:15 PMScilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreementglobenewswire.com - February 26 at 4:53 PMScilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Metglobenewswire.com - February 26 at 9:00 AMScilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹globenewswire.com - February 20 at 9:00 AMScilex Holding (NASDAQ:SCLX) Short Interest Updatemarketbeat.com - February 16 at 6:25 AMSCLX Sees Accelerating Revenue Growthfinance.yahoo.com - January 30 at 12:33 PMBuy Rating Affirmed for Scilex Holding Amid Strong Product Performance and Improved Financial Outlookmarkets.businessinsider.com - January 26 at 11:56 PMHC Wainwright Weighs in on Scilex Holding's FY2023 Earnings (NASDAQ:SCLX)marketbeat.com - January 25 at 6:52 AMSCLX Jan 2024 2.000 putfinance.yahoo.com - January 23 at 9:02 PMScilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024finance.yahoo.com - January 8 at 9:12 AM Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. SCLX Media Mentions By Week SCLX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCLX News Sentiment▼0.340.56▲Average Medical News Sentiment SCLX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCLX Articles This Week▼42▲SCLX Articles Average Week Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CLLS News MOLN News CRDL News DBVT News VXRT News OMGA News CGEN News OTLK News KOD News ELEV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCLX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
